Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - Relation to Th1- and Th2-derived cytokines

Clinical and Experimental Immunology

Volumn 116, Issue 1, 1999, Pages 169-173

  Tokano, Yoshiaki ^a   Morimoto, S ^a   Kaneko, H ^a   Amano, H ^a   Nozawa, K ^a   Takasaki, Y ^a   Hashimoto, H ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

IL 12; IL 13; Interferon gamma; Systemic lupus erythematosus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION;

ADULT; AUTOIMMUNITY; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-6; INTERLEUKINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 0032927145     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00862.x     Document Type: Article

References (32)

1. 1 Chehimi J, Valiante NM, D'Andrea A et al. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected. Eur J Immunol 1993; 23:1826-30.
2. 2 Sousa CR, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, Sher A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med 1997; 186:1819-29.
3. 3 Kobayashi M, Fitz L, Ryan M et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170:827-45.
4. 4 Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993; 177:1505-9.
5. 5 Huang F-P, Feng G-J, Lindop G, Stott DI, Liew FY. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med 1996; 183:1447-59.
6. 6 Huang Y-P, Perrin LH, Miescher PA. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol 1988; 141:827-33.
7. 7 Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, OzeriChen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991; 147:117-23.
8. 8 Al-Janadi M, Al-Bulla S, Al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13:58-67.
9. 9 Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, Galanaud P, Emilie D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994; 37:1647-55.
10. 10 Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer J-P, Renauld J-C. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995; 4:393-5.
11. 11 Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different function properties. Ann Rev Immunol 1989; 7:145-73.
12. 12 Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Isui S. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996; 97:1597-604.
13. 1 mice. Lupus 1995; 4:213-6.
14. 14 Gros GL, Ben-Sasson SZ, Seder R, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990; 172:921-9.
15. 15 Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
16. 16 Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI A disease activity index for lupus patients. Arthritis Rheum 1992; 35:630-40.
17. 17 Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 1995; 80:707-18.
18. 18 Stüber E, Strober W, Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996; 183:693-8.
19. 19 Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84:4008-27.
20. 20 Hosken NA, Shibuya K, Heath AW, Murphy KM, O'Garra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor αβ transgenic model. J Exp Med 1995; 182:1579-84.
21. 21 Tamura T, Nakano H, Nagase H, Morokata T, Igarashi O, Oshimi Y, Miyazaki S, Nariuchi H. Early activation signal transduction pathways of Th1 and Th2 cell clones stimulated with anti-CD3. J Immunol 1995; 155:4692-701.
22. 22 Rook GAW, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994; 15:301-3.
23. 23 Shankar AH, Titus RG. T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med 1995; 181:845-55.
24. 24 Pfeiffer C, Murray J, Madri J, Bottomly K. Selective activation of Th1-and Th2-Iike cells in vivo - response to human collagen IV. Immunol Rev 1991; 123:68-84.
25. 25 Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16:34-38.
26. 26 Horwitz DA, Wang H, Gray JD. Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but interleukin-4 m-RNA. Lupus 1994; 3:423-8.
27. 27 D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin-10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178:1041-8.
28. 28 Meyaard L, Hovenkamp E, Otto SA, Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 1996; 156:2776-82.
29. 29 Jeannin P, Delneste Y, Seveso M, Life P, Bonnefoy J-Y. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J Immunol 1996; 156:3159-65.
30. 30 Minty A, Chalon P, Derocq J-M et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362:248-50.
31. 31 Malefyt RW, Figdor CG, Huijbens R et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocyte. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993; 151:6370-81.
32. 1 mice. J Immunol 1997; 158:1466-72.